[HTML][HTML] Oxypurinol-specific T cells possess preferential TCR clonotypes and express granulysin in allopurinol-induced severe cutaneous adverse reactions
WH Chung, RY Pan, MT Chu, SW Chin… - Journal of Investigative …, 2015 - Elsevier
Allopurinol, a first-line drug for treating gout and hyperuricemia, is one of the leading causes
of severe cutaneous adverse reactions (SCARs). To investigate the molecular mechanism of …
of severe cutaneous adverse reactions (SCARs). To investigate the molecular mechanism of …
[引用][C] Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions
WH Chung, RY Pan, MT Chu, SW Chin… - Journal of Investigative …, 2015 - cir.nii.ac.jp
Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in
Allopurinol-Induced Severe Cutaneous Adverse Reactions | CiNii Research CiNii 国立情報学 …
Allopurinol-Induced Severe Cutaneous Adverse Reactions | CiNii Research CiNii 国立情報学 …
[PDF][PDF] Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions
WH Chung, RY Pan, MT Chu, SW Chin… - Journal of Investigative …, 2015 - academia.edu
Allopurinol, a xanthine oxidase inhibitor, is currently a firstline drug for the treatment of gout
and hyperuricemia (Braden et al., 1994). Although generally well tolerated, allopurinol is …
and hyperuricemia (Braden et al., 1994). Although generally well tolerated, allopurinol is …
Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions
WH Chung, RY Pan, MT Chu… - The Journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Allopurinol, a first-line drug for treating gout and hyperuricemia, is one of the leading causes
of severe cutaneous adverse reactions (SCARs). To investigate the molecular mechanism of …
of severe cutaneous adverse reactions (SCARs). To investigate the molecular mechanism of …
Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions.
WH Chung, RY Pan, MT Chu, SW Chin… - The Journal of …, 2015 - europepmc.org
Allopurinol, a first-line drug for treating gout and hyperuricemia, is one of the leading causes
of severe cutaneous adverse reactions (SCARs). To investigate the molecular mechanism of …
of severe cutaneous adverse reactions (SCARs). To investigate the molecular mechanism of …
[PDF][PDF] Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions
WH Chung, RY Pan, MT Chu, SW Chin… - Journal of Investigative …, 2015 - core.ac.uk
Allopurinol, a xanthine oxidase inhibitor, is currently a firstline drug for the treatment of gout
and hyperuricemia (Braden et al., 1994). Although generally well tolerated, allopurinol is …
and hyperuricemia (Braden et al., 1994). Although generally well tolerated, allopurinol is …
[PDF][PDF] Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions
WH Chung, RY Pan, MT Chu, SW Chin… - Journal of …, 2015 - scholar.archive.org
Allopurinol, a xanthine oxidase inhibitor, is currently a firstline drug for the treatment of gout
and hyperuricemia (Braden et al., 1994). Although generally well tolerated, allopurinol is …
and hyperuricemia (Braden et al., 1994). Although generally well tolerated, allopurinol is …
[PDF][PDF] Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions
WH Chung, RY Pan, MT Chu, SW Chin… - Journal of Investigative …, 2015 - academia.edu
Allopurinol, a xanthine oxidase inhibitor, is currently a firstline drug for the treatment of gout
and hyperuricemia (Braden et al., 1994). Although generally well tolerated, allopurinol is …
and hyperuricemia (Braden et al., 1994). Although generally well tolerated, allopurinol is …